ВОССТАНОВЛЕНИЕ В-КЛЕТОЧНОГО ИММУНИТЕТА ПОСЛЕ АЛЛОГЕННОЙ ТРАНСПЛАНТАЦИИ ГЕМОПОЭТИЧЕСКИХ СТВОЛОВЫХ КЛЕТОК

Восстановление В-клеточного звена иммунитета – это ключевая составляющая успешности аллогенной трансплантации гемопоэтических стволовых клеток. В большинстве случаев восстановление В-лимфопоэза является медленным и часто незавершенным процессом, который сопровождается снижением толерантности реципиента к бактериальным, вирусным, грибковым патогенам. На этот процесс оказывает влияние ряд факторов, определяющих его эффективность и темп. Важно восстановление не только численности В-клеточной популяции, но и их функциональной полноценности. В статье проводится анализ современных данных литературы о значимости восстановления В-клеточного иммунитета после аллогенной трансплантации гемопоэтических стволовых клеток, обзор основных факторов, влияющих на процесс В-лимфопоэза, и их прогностической составляющей.

1. Young J.H., Logan B.R., Wu J. et al. Infections after transplantation of bone marrow or peripheral blood stem cells from unrelated donors. Biol Blood Marrow Transplant 2016;22(2):359–70. DOI: 10.1016/j.bbmt.2015.09.013.

2. Pasquini M.C., Zhu X. Current use and outcome of hematopoietic stem cell transplantation: CIBMTR Summary Slides, 2015. Available by: http://www.cibmtr.org.

3. Socie G., Stone J.V., Wingard J.R. et al. Long-term survival and late deaths after allogeneic bone marrow transplantation. Late effects working committee of the international bone marrow transplant registry. N Engl J Med 1999;341:14–21. DOI: 10.1056/NEJM199907013410103.

4. Eapen M., Rocha V., Sanz G. et al. Effect of graft source on unrelated donor haemopoietic stem-cell transplantation in adults with acute leukaemia: a retrospective analysis. Lancet Oncol 2010;11:653–60. DOI: 10.1016/S1470-2045(10)70127-3.

5. Parody R., Martino R., Rovira M. et al. Severe infections after unrelated donor allogeneic hematopoietic stem cell transplantation in adults: comparison of cord blood transplantation with peripheral blood and bone marrow transplantation. Biol Blood Marrow Transplant 2006;12:734–48. DOI: 10.1016/j. bbmt.2006.03.007.

6. Thomas E.D., Lochte H.L.Jr, Lu W.C., Ferrebee J.W. Intravenous infusion of bone marrow in patients receiving radiation and chemotherapy. New Engl J Med 1957;257(11):491–6. DOI: 10.1056/NEJM195709122571102.

7. Mathé G., Amiel J.L., Schwarzenberg L. et al. Successful allogeneic bone marrow transplantation in man: сhimerism induced specific tolerance and possible antileukemic effects. Blood 1965;25:179–96.

8. Субботина Н.Н., Долгополов И.С., Попа А.В. и др. Гаплоидентичная трансплантация гемопоэтических стволовых клеток у детей с острыми миелоидными лейкозами: эволюция метода и собственные данные. Онкогематология 2014;7(2):131–6. Subbotina N.N., Dolgopolov I.S., Popa A.V. et al. Haploidentical hematopoietic stem cell transplantation in children with acute myeloid leukemia: evolution of the method and own data. Onkohematologyya = Oncohematology 2014;7(2):131–6. (In Russ.)].

9. Рукавицын О.А. Гематология: национальное руководство. М.: ГЭОТАРМедиа, 2015. 776 с. [Rukavitsyn O.A. Hematology: national leadership. Moscow: GEOTAR-Media, 2015. 776 p. (In Russ.)].

10. Грицаев С.В., Павлова И.Е., Семенова Н.Ю. Отдельные аспекты трансплатации гемопоэтических стволовых клеток онкогематологическим больным. Вестник гематологии 2015;11(3):9–28. [Gritsaev S.V., Pavlova I.E., Semenova N.Yu. Some aspects of hematopoietic stem cell transplantation to oncohematological patients. Vestnik gematologii = Bulletin of Hematology 2015;11(3):9–28. (In Russ.)].

11. Carreras E., Rambaldi A. Evaluation and Counseling of Candidates. Eds.: E. Carreras, C. Dufour, M. Mohty, N. Kröger. The EBMT Handbook: Hematopoietic Stem Cell Transplantation and Cellular Therapies. 7th Ed. Cham (CH): Springer, 2019;11.

12. Sauter C., Abboud M., Jia X. et al. Serious infection risk and immune recovery after double-unit cord blood transplantation without antithymocyte globulin. Biol Blood Marrow Transplant 2011;17(10):1460–71. DOI: 10.1016/j.bbmt.2011.02.001.

13. Winston D.J., Gale R.P., Meyer D.V., Young L.S. Infectious complications of human bone marrow transplantation. Med (Baltimore) 1979;58:1–31. DOI: 10.1097/00005792-197901000-00001.

14. Atkinson K., Storb R., Prentice R.L. et al. Analysis of late infections in 89 long-term survivors of bone marrow transplantation. Blood 1979;53:720–31.

15. Kolb H.J. Graft-versus-leukemia effects of transplantation and donor lymphocytes. Blood 2008;112(12):4371–83. DOI: 10.1182/blood-2008-03-077974.

16. Horowitz M.M., Gale R.P., Sondel P.M. et al. Graft-versus-leukemia reactions after bone marrow transplantation. Blood 1990;75(3):555–62. DOI: 10.1182/blood.V75.3.555.bloodjournal753555.

17. Мелкова К.Н., Петрова Г.Д., Горбунова Н.В. и др. Классификация режимов кондиционирования: исторические предпосылки и современные представления. Клиническая онкогематология 2017;10(4):494–500. [Melkova K.N., Petrova G.D., Gorbunova N.V. et al. Classification of conditioning modes: historical background and current understanding. Klinicheskaya onkogematologiya = Clinical Oncohematology 2017;10(4): 494–500. (In Russ.)]. DOI: 10.21320/2500-2139-2017-10-4-494-5.

18. Гривцова Л.Ю. Дифференцированный прогноз трансплантации стволовых клеток в онкологии. Автореф. дис. ... д-ра биол. наук. М., 2015. [Grivtsova L.Yu. Differentiated prognosis of stem cell transplantation in oncology. Abstract of the dissertation of a doctor of biological sciences. Moscow, 2015. (In Russ.)].

19. Williams K.M., Gress R.E. Immune reconstitution and implications for immunotherapy following haematopoietic stem cell transplantation. Best Pract Res Clin Haematol 2008;21(3): 579–96. DOI: 10.1016/j.beha.2008.06.003.

20. Fujimaki K., Maruta A., Yoshida M. et al. Immune reconstitution assessed during five years after allogeneic bone marrow transplantation. Bone Marrow Transplant 2001;27(12):1275–81. DOI: 10.1038/sj.bmt.1703056.

21. Komanduri K.V., St John L.S., de Lima M. et al. Delayed immune reconstitution after cord blood transplantation is characterized by impaired thymopoiesis and late memory T-cell skewing. Blood 2007;110:4543–51. DOI: 10.1182/blood-2007-05-092130.

22. Ringhoffer S., Rojewski M., Dohner H. et al. T-cell reconstitution after allogeneic stem cell transplantation: assessment by measurement of the sjTREC/βTREC ratio and thymic naive T-cells. Haematologica 2013;98:1600–8. DOI: 10.3324/haematol.2012.072264.

23. Di Ianni M., Falzetti F., Carotti A. et al. Tregs prevent GVHD and promote immune reconstitution in HLA-haploidentical transplantation. Blood 2011;117(14):3921–8. DOI: 10.1182/blood-2010-10-311894.

24. Mehta R.S., Rezvani K. Immune reconstitution post allogeneic transplant and the impact of immune recovery on the risk of infection. Virulence 2016;7(8):901–16. DOI: 10.1080/21505594.2016.1208866.

25. Storek J., Geddes M., Khan F. et al. Reconstitution of the immune system after hematopoietic stem cell transplantation in humans. Semin Immunopathol 2008;30(4):425–37. DOI: 10.1007/s00281-008-0132-5.

26. Bosch M., Khan F.M., Storek J. Immune reconstitution after hematopoietic cell transplantation. Curr Opin Hematol 2012;19(4):324–35. DOI: 10.1097/MOH.0b013e328353bc7d.

27. Storek J., Ferrara S., Ku N. et al. B cell reconstitution after human bone marrow transplantation: recapitulation of ontogeny? Bone Marrow Transplant 1993;12(4):387–98.

28. Gerritsen E.J, van Tol M.J., Lankester A.C. et al. Immunoglobulin levels and monoclonal gammopathies in children after bone marrow transplantation. Blood 1993;82(11):3493–502.

29. Гривцова Л.Ю., Глухов Е.В., Чулкова С.В. и др. Особенности В-клеточного звена иммунитета у больных раком желудка после спленэктомии. Иммунология 2014;35(5):279–86. [Grivtsova L.Yu., Glukhov E.V., Chulkova S.V. et al. Features of B-cell immunity in patients with gastric cancer after splenectomy. Immunologiya = Immunology 2014;35(5):279–86. (In Russ.)].

30. Burns D.M., Tierney R., Shannon-Lowe C. et al. Memory B cell reconstitution following allogeneic haematopoietic stem cell transplantationis an EBV-associated transformation event. Blood 2015;126(25):2665–75. DOI: 10.1182/blood-2015-08-665000.

31. Marie-Cardine A., Divay F., Dutot I. et al. Transitional B cells in humans: characterization and insight from B lymphocyte reconstitution after hematopoietic stem cell transplantation. Clin Immunol 2008;127:14–25. DOI: 10.1016/j.clim.2007.11.013.

32. Чулкова С.В., Шолохова Е.Н., Грищенко Н.В. и др. Ключевая роль популяции В-1 в иммунном ответе у больных раком желудка. Российский биотерапевтический журнал 2018;17(4):64–70. DOI: 10.17650/1726-9784-2018-17-4-64-70. [Chulkova S.V., Sholokhova E.N., Grishchenko N.V. et al. The role of B-1 lymphocytes in antitumor immunity in patients with gastric cancer. Rossiyskiy bioterapevticheskiy zhurnal = Russian Journal of Biotherapy 2018;17(4):64–70. (In Russ)].

33. Sims G.P., Ettinger R., Shirota Y. et al. Identification and characterization of circulating human transitional B cells. Blood 2005;105:4390–8. DOI: 10.1182/blood-2004-11-4284.

34. Klein U., Rajewsky K., Kuppers R. Human immunoglobulin (Ig)M+ IgD+ peripheral blood B cells expressing the CD27 cell surface antigen carry somatically mutated variable region genes: CD27 as a general marker for somatically mutated (memory) B-cells. J Exp Med 1998;188:1679–89. DOI: 10.1084/jem.188.9.1679.

35. Storek J., Dawson M.A., Storer B. et al. Immune reconstitution after allogeneic marrow transplantation compared with blood stem cell transplantation. Blood 2001;97:3380–9. DOI: 10.1182/blood.V97.11.3380.

36. Jacobson C.A., Turki A.T., McDonough S.M. et al. Immune reconstitution after double umbilical cord blood stem cell transplantation: comparison with unrelated peripheral blood stem cell transplantation. Biol Blood Marrow Transplant 2012;18:565–74. DOI: 10.1016/j.bbmt.2011.08.018.

37. Bejanyan N., Brunstein Claudio G., Cao Qing et al. Delayed immune reconstitution after allogeneic transplantation increases the risks of mortality and chronic GVHD. Blood Adv 2018;2(8): 909–22. DOI: 10.1182/bloodadvances.2017014464.

38. Abdel-Azim H., Elshoury A., Mahadeo Kris M. et al. Humoral immune reconstitution kinetics after allogeneic hematopoietic stem cell transplantation in children: a maturation block of IgM memory B cells may lead to impaired antibody immune reconstitution. Biol Blood Marrow Transplant 2017;23(9):1437–46. DOI: 10.1016/j.bbmt.2017.05.005.

39. Kalwak K., Gorczyńska E., Toporski J. et al. Immune reconstitution after haematopoietic cell transplantation in children: immunophenotype analysis with regard to factors affecting the speed of recovery. Br J Haematol. 2002;118(1):74–89. DOI: 10.1046/j.1365-2141.2002.03560.x.

40. Clave E., Busson M., Douay C. et al. Acute graft-versus-host disease transiently impairs thymic output in young patients after allogeneic hematopoietic stem cell transplantation. Blood 2009;113(25):6477–84. DOI: 10.1182/blood-2008-09-176594.

41. Petersen S.L., Ryder L.P., Bjork P. et al. A comparison of T-, B- and NK-cell reconstitution following conventional or nonmyeloablative conditioning and transplantation with bone marrow or peripheral blood stem cells from human leucocyte antigen identical sibling donors. Bone Marrow Transplant 2003;32(1):65–72. DOI: 10.1038/sj.bmt.1704084.

42. Shono Y., Ueha S., Wang Y. et al. Bone marrow graft-versus-host disease: early destruction of hematopoietic niche after MHC-mismatched hematopoietic stem cell transplantation. Blood 2010;115(26):5401–11. DOI: 10.1182/blood-2009-11-253559.

43. Waller E.K., Logan B.R., Fei M. et al. Kinetics of immune cell reconstitution predict survival in allogeneic bone marrow and G-CSF-mobilized stem cell transplantation. Blood Adv 2019;3(15):2250–63. DOI: 10.1182/bloodadvances.2018029892.

44. Peterson P.K., McGlave P., Ramsay N.K. et al. A prospective study of infectious diseases following bone marrow transplantation: emergence of Aspergillus and Cytomegalovirus as the major causes of mortality. Infect Control 1983;4(2):81–9. DOI: 10.1017/s0195941700057805.

45. Marek A., Stern M., Chalandon Y. et al. The impact of T-cell depletion techniques on the outcome after haploidentical hematopoietic SCT. Bone Marrow Transplant 2014;49:55–61. DOI: 10.1038/bmt.2013.132.

46. Aversa F., Pierini A., Ruggeri L. et al. The Evolution of T Cell Depleted Haploidentical Transplantation. Front Immunol 2019;10:2769. DOI: 10.3389/fimmu.2019.02769.

47. Storek J., Wells D., Dawson M.A. et al. Factors influencing B lymphopoiesis after allogeneic hematopoietic cell transplantation. Blood 2001;98(2):489–91. DOI: 10.1097/00007890-200204150-00026.

48. Remberger M., Ringd´en O., Blau I.W. et al. No difference in graft-versus-host disease, relapse, and survival comparing peripheral stem cells to bone marrow using unrelated donors. Blood 2001;98(6):1739–45. DOI: 10.1182/blood.V98.6.1739.

49. Zorn E., Kim H.T., Lee S.J. et al. Reduced frequency of FOXP3+CD4+CD25+ regulatory T cells in patients with chronic graft-versus-host disease. Blood 2005;106(8):2903–11. DOI: 10.1182/blood-2005-03-1257.

50. Sarantopoulos S., Stevenson K.E., Kim H.T. et al. Altered B-cell homeostasis and excess BAFF in human chronic graft-versus-host disease. Blood 2009;113(16):3865–74. DOI: 10.1182/blood-2008-09-177840.

51. Sarantopoulos S., Stevenson K.E., Kim H.T. et al. Recovery of B-cell homeostasis after rituximab in chronic graft-versus-host disease. Blood 2011;117(7):2275–83. DOI: 10.1182/blood-2010-10-307819.

52. Waller E.K., Logan B.R., Harris W.A. et al. Improved survival after transplantation of more donor plasmacytoid dendritic or naıve T cells from unrelateddonor marrow grafts: results from BMTCTN 0201. J Clin Oncol 2014;32(22):2365–72. DOI: 10.1200/JCO.2013.54.4577.

53. Matsue K., Lum L.G., Witherspoon R.P., Storb R. Proliferative and differentiative responses of B cells from human marrow graft recipients to T cell-derived factors. Blood 1987;69:308–15.

54. Szabolcs P., Niedzwiecki D. Immune reconstitution after unrelated cord blood transplantation. Cytotherapy 2007;9(2):111–22. DOI: 10.1080/14653240701231014.